INS and Parkinson disease: Furthermore, pretreatment with the rosiglitazone (an insulin sensitizer) attenuates striatal DA neurodegeneration in 6‐OHDA‐lesioned model of PD by increase in GFAP expression and astrocyte function in the SNpc and striatum.56